Literature DB >> 3972808

Rates of amphotericin B and filipin association with sterols. A study of changes in sterol structure and phospholipid composition of vesicles.

S Clejan, R Bittman.   

Abstract

The influence of structural modifications in sterols and phospholipids on the rate of polyene antibiotic-sterol interaction was studied. For filipin and amphotericin B association with sterols in vesicles, a preferential interaction was found with sterols whose side chain length is close to that of cholesterol. Introduction of trans double bonds into the sterol side chain did not alter the rate of interaction in vesicles. The delta 7-bond of the sterol appears to be of critical importance in amphotericin B-sterol interaction, whereas the delta 5-bond is not essential. These observations are relevant to the well-known effects of amphotericin B on cell membranes containing ergosterol compared with those containing cholesterol. The dependence of the rates of sterol-polyene antibiotic interaction on the phospholipid composition of the vesicles indicates that phospholipid vesicles may be an inadequate model for reaching a comprehensive understanding of the effects exerted on biological membranes by these agents.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972808

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol.

Authors:  Yvonne Maria te Welscher; Lynden Jones; Martin Richard van Leeuwen; Jan Dijksterhuis; Ben de Kruijff; Gary Eitzen; Eefjan Breukink
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

2.  Antibodies to nystatin demonstrate polyene sterol specificity and allow immunolabeling of sterols in Saccharomyces cerevisiae.

Authors:  H M Walker-Caprioglio; J M MacKenzie; L W Parks
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

3.  High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance.

Authors:  S A Yoon; J A Vazquez; P E Steffan; J D Sobel; R A Akins
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

4.  Conformational properties of amphotericin B amide derivatives--impact on selective toxicity.

Authors:  H Resat; F A Sungur; M Baginski; E Borowski; V Aviyente
Journal:  J Comput Aided Mol Des       Date:  2000-10       Impact factor: 3.686

5.  Salvage treatment with amphotericin B in progressive human alveolar echinococcosis.

Authors:  Stefan Reuter; Andreas Buck; Olaf Grebe; Karin Nüssle-Kügele; Peter Kern; Burkhard J Manfras
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

6.  FTIR spectroscopic study of molecular organization of the antibiotic amphotericin B in aqueous solution and in DPPC lipid monolayers containing the sterols cholesterol and ergosterol.

Authors:  Mariusz Gagoś; Marta Arczewska
Journal:  Eur Biophys J       Date:  2012-07-26       Impact factor: 1.733

7.  Effect of amphotericin B on larval growth of Echinococcus multilocularis.

Authors:  Stefan Reuter; Marion Merkle; Klaus Brehm; Peter Kern; Burkhard Manfras
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  Filipin fluorescence quenching by spin-labeled probes: studies in aqueous solution and in a membrane model system.

Authors:  M Castanho; M Prieto
Journal:  Biophys J       Date:  1995-07       Impact factor: 4.033

9.  Towards New Insights in the Sterol/Amphotericin Nanochannels Formation: A Molecular Dynamic Simulation Study.

Authors:  Khaoula Boukari; Sébastien Balme; Jean-Marc Janot; Fabien Picaud
Journal:  J Membr Biol       Date:  2015-12-23       Impact factor: 1.843

10.  Comparative conformational analysis of cholesterol and ergosterol by molecular mechanics.

Authors:  M Bagiński; A Tempczyk; E Borowski
Journal:  Eur Biophys J       Date:  1989       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.